No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr11:34518400-34534800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
2 |
chr11:34521200-34524000 |
Enhancers |
Adipose Nuclei |
Adipose
|
3 |
chr11:34521600-34524400 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
4 |
chr11:34521800-34523400 |
Enhancers |
HepG2 |
liver
|
5 |
chr11:34521800-34523800 |
Weak transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
6 |
chr11:34521800-34524200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
7 |
chr11:34522000-34524200 |
Enhancers |
Gastric |
stomach
|
8 |
chr11:34522400-34524400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
9 |
chr11:34522400-34524600 |
Enhancers |
NH-A |
brain
|
10 |
chr11:34522600-34523200 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
11 |
chr11:34522600-34523200 |
Enhancers |
Lung |
lung
|
12 |
chr11:34522600-34523600 |
Enhancers |
HSMM |
muscle
|
13 |
chr11:34522600-34523600 |
Enhancers |
Osteobl |
bone
|
14 |
chr11:34522600-34524200 |
Enhancers |
NHDF-Ad |
bronchial
|
15 |
chr11:34522600-34524400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
16 |
chr11:34522600-34524400 |
Enhancers |
HSMMtube |
muscle
|
17 |
chr11:34522600-34524600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
18 |
chr11:34522600-34524600 |
Enhancers |
Liver |
Liver
|
19 |
chr11:34522600-34524600 |
Enhancers |
Fetal Lung |
lung
|
20 |
chr11:34522800-34523200 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
21 |
chr11:34522800-34523800 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
22 |
chr11:34522800-34524000 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
23 |
chr11:34522800-34524000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
24 |
chr11:34522800-34524200 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
25 |
chr11:34522800-34524200 |
Enhancers |
Placenta |
Placenta
|
26 |
chr11:34522800-34524400 |
Flanking Active TSS |
Hela-S3 |
cervix
|
27 |
chr11:34522800-34524400 |
Enhancers |
NHLF |
lung
|
28 |
chr11:34522800-34524600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
29 |
chr11:34522800-34524600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
30 |
chr11:34523000-34523400 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
31 |
chr11:34523000-34523800 |
Enhancers |
HMEC |
breast
|
32 |
chr11:34523000-34524000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
33 |
chr11:34523000-34524000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
34 |
chr11:34523000-34524200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
35 |
chr11:34523000-34524200 |
Enhancers |
Brain Anterior Caudate |
brain
|
36 |
chr11:34523000-34524200 |
Enhancers |
Spleen |
Spleen
|